Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells by unknown
Brief De~nRive  Report 
Interferon V Regulates Antigen-induced Eosinophil 
Recruitment into the Mouse Airways by Inhibiting 
the Infiltration of CD4 + T  Cells 
By Itsuo Iwamoto, Hiroshi Nakajima, Hideharu Endo, 
and Sho Yoshida 
From The Second Department of Internal Medicine, Chiba University School of Medicine, 
Chiba 260, Japan 
Summary 
We have previously shown that antigen-induced eosinophil recruitment into the tissue of sensitized 
mice is mediated by CD4 + T cells and interleukin 5. To determine whether interferon 3' (IFN-3,) 
regulates antigen-induced eosinophll recruitment into the tissue, we studied the effect of  recombinant 
(r) murine IFN-3, and of anti-IFN-3, monoclonal antibody (mAb) on the eosinophil infiltration 
of the trachea induced by antigen inhalation in mice. The intraperitoneal administration of rlFN-3, 
prevented antigen-induced eosinophil infiltration in the trachea of sensitized mice. The administration 
of rIFN-3, also decreased antigen-induced CD4 + T cell but not CD8 + T cell infiltration in the 
trachea. On the other hand, pretreatment with anti-IFN-'y mAb enhanced antigen-induced eosino- 
phil and CD4 + T  cell infiltration in the trachea. These results indicate that IFN-3, regulates 
antigen-induced eosinophil recruitment into the tissue by inhibiting CD4 + T  cell infiltration. 
E 
osinophil infiltrate is a characteristic feature of allergic 
inflammation such as asthma. In a murine model of airway 
late-phase  reaction, we have previously shown that antigen- 
induced eosinophil recruitment into the tissue of sensitized 
mice is mediated by CD4 + T  cells and IL-5 (1). However, 
the  mechanism  that  regulates  antigen-induced eosinophil 
recruitment into the tissue is unknown. It has been suggested 
that CD4 + Th cells can be divided into two subsets  (Thl 
and Th2 cells) on the basis of their different patterns of  cytokine 
secretion (2); Thl cells produce Ib2, IFN-3,, and lymphotoxin, 
and Th2 cells produce Ib4, IL-5, and Ib6. Furthermore, IFN-3, 
has been shown to be a major regulatory cytokine that in- 
hibits the proliferation of Th2 cells in vitro (3,  4) and an- 
tagonizes  the  in  vivo  Th2-type  responses  such  as  IL-4- 
dependent IgE antibody production (5). Therefore, to deter- 
mine whether IFN-3,  regulates antigen-induced eosinophil 
recruitment into the tissue,  we studied the effect of recom- 
binant murine IFN-3' and of anti-IFN-3, mAb on the eosin- 
ophil infiltration of the trachea induced by antigen inhala- 
tion  in  mice.  Our  results  indicate  that  IFN-3,  regulates 
antigen-induced eosinophil recruitment into the tissue by in- 
hibiting CD4 § T  cell infiltration. 
Materials and Methods 
Mice and Immunization.  8-wk-old  BALB/c  mice (Charles River 
Laboratories, Shizuoka, Japan) were immunized intraperitoneally 
twice with 1 #g of OVA (Sigma Chemical Co., St. Louis, MO) 
in 4 mg of aluminum hydroxide at a 2-wk interval. 10-14 d after 
the second immunization, the sensitized  mice were challenged  with 
aerosolized OVA as described below. 
Antigen-induced Eosinophil lnfihration in Mouse Trachea.  The eo- 
sinophil infiltration into the trachea was induced by the inhalation 
of antigen  in  sensitized mice, and  the  number  of eosinophils 
infiltrating into the submucosal tissue of trachea was evaluated as 
described previously (1). Briefly, the sensitized mice inhaled aero- 
solized OVA (50 mg/ml) dissolved  in 0.9%  saline by a nebulizer 
(646; DeVilbiss Corp., Somerset, PA) for 20 min. As a control, 
0.9% saline alone was administered by the nebulizer. At various 
intervals after the inhalation, the mice were killed by cervical dislo- 
cation and the tracheas were excised. After the tracheas were fixed 
in 10% formalin, the specimens were embedded in parafl:m, sec- 
tioned 3/zm thick, and stained with Luna solution and hematoxylin- 
eosin solution. The number ofeosinophils in the submucosal tissue 
of trachea was counted in Luna-stained sections and expressed as 
the number of eosinophils per the length of the basement mem- 
brane of trachea, which was measured with a digital curvimeter. 
Effect of Murine rlFN-'g.  To determine whether IFN-3, has a 
regulatory role in antigen-induced eosinophil recruitment into the 
tissue, we examined  the effect  of  murine rlFN-v on antigen-induced 
eosinophil infiltration in  the  trachea of sensitized mice. OVA- 
sensitized mice were injected  intraperitoneally  with murine rlFN-y 
(300-30,000 U; Genentech, Inc., South San Francisco, CA) every 
12 h from 1 d before the inhaled OVA challenge until 24 h after 
the challenge. As a control, OVA-sensitized  mice were injected in- 
traperitoneally with saline. The eosinophil infiltration into the tra- 
chea was evaluated at 9, 24, and 48 h after OVA inhalation. 
Effect of Anti-Murine IFN-'g mAh  To determine whether en- 
dogenous IFN-y is involved  in regulating antigen-induced eosino- 
phil recruitment into the tissue, we examined  the effect  of  anti-mu- 
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trachea of sensitized mice. OVA-sensitized mice were injected in-  ~n ~ 
traperitoneally once with 1 mg of rat anti-murine IFN-'y mAb  "~...  20- 
(K4-6A2) (6) 24 h before the inhaled OVA challenge. As a control,  .o  ~  15 
OVA-sensitized mice were injected intraperitoneally with purified  ~, 
rat IgG (1 mg) 24 h before the inhaled OVA challenge. The eosino-  m  c  10 
phil infiltration into the trachea was evaluated at 9 and 24 h after 
OVA inhalation.  5 
Immunocytochemistry.  T cell infiltration into the trachea was as-  0  t 
sessed by direct staining with streptavidin-biotinylated antibody  0 
technique (7).  Briefly, the trachea was removed and frozen with 
OCT compound (Miles Laboratories,  Naperville, IL) in a liquid  25 
nitrogen bath. After acetone-fixed cryostat sections (3 #m thick)  cn "g 
were treated with normal rabbit serum, the sections were incubated  '~o_---E 20 
with  biotinylated anti-Thy-l.2,  anti-L3T4,  or anti-Lyt-2 mAbs  .o ~  15 
(Becton Dickinson & Co., Mountain View, CA) at room tempera-  ~  E 
ture for 2 h. As a negative control, biotinylated normal rat IgG  m  ~  10 
was used. Sections were then incubated with the streptavidin con-  5 
jugated with horseradish  peroxidase (Vector Laboratories,  Burlin- 
game, CA) at room temperature for 30 min, followed by the reac-  0 
tion with 3', 3-diaminobenzidine in Tris-HCl buffer containing 
H2Oz for 5 min. The immunostained cells were counted and ex- 
pressed  as described above. 
Data Analysis.  Data  are  summarized  as  mean  _+  SD.  The 
statistical  analysis of the results was performed by the analysis of 
variance using Fisher's least significant difference test for multiple 
comparisons. Values of p <0.05 were considered significant. 
Results 
Kinetics of Antigen-induced Eosinophil and T Cell Infiltration 
into the Mouse Trachea.  The inhalation of aerosolized OVA 
caused the infiltration of eosinophils into the trachea of OVA- 
sensitized mice. The eosinophil infiltration into the tracheal 
submucosa of OVA-sensitized BALB/c mice began at 6 h after 
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Figure  1.  Time course of antigen-induced  eosinophil  and T cell infiltra- 
tion into the mouse trachea. OVA-sensitized  BALB/c  mice were challenged 
with the inhalation of OVA, and the number of eosinophils and T cells 
(CD4 + [I] and CD8 + [A]) infiltrating into the submucosal tissue of 
trachea was counted at various  intervals  after the inhalation. Data are means 
_+  SD for 10 mice at each time point. 
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Figure 2.  Effect  ofmurine rlFN~ on antigen-induced  eosinophil  infiltra- 
tion in  mouse trachea. (~p)  OVA-sensitized mice were injected in- 
traperitoneally  with routine rlFN-3, or saline from 1 d before the inhaled 
OVA challenge until 24 h after the challenge (saline [0] 6,000 U/d [&], 
and 60,000 U/d lIB]; n  =  5-6 mice in each group.) The mean values 
in the treated group are significantly  different from the mean value of the 
corresponding control response (saline), p <0.001. (Bottom) The dose- 
dependent effect of rlFN-3, (600-60,000 U/d) on the eosinophil infiltra- 
tion was examined at 24 h (n  =  5 mice in each group). (* and **) 
Significantly different from the mean value of the control response (sa- 
line): *p <0.01; **p <0.001. 
OVA inhalation, increased at 9-24 h, and then reached a pla- 
teau (n  =  10 mice at each time point) (Fig. 1). The antigen- 
induced eosinophil recruitment into the mouse trachea was 
shown  to be mediated  by CD4 +  T  cells  and  IL-5  in  our 
previous study (1). 
CD4 + and CD8 + T  cell infiltration into the trachea also 
occurred 2 h  after OVA inhalation and increased to reach a 
peak at 12 h (n  =  10 mice at each time point) (Fig. 1). The 
majority of T  cell infiltrates (70-75%) were CD4 + T  cells 
(Fig.  1). 
Effect of lFN-7 on Antigen-induced Eosinophil Infiltration into 
the  Trachea.  IFN-y  prevented  antigen-induced  eosinophil 
recruitment into the mouse trachea. The intraperitoneal prein- 
jection with rlFN-y (6,000 U/d) from 1 d before the inhaled 
OVA challenge significantly decreased OVA-induced eosino- 
phil infiltration into the trachea of OVA-sensitized mice at 
9-48 h by 78-87% (control [18.2  +_  4.9] vs. rIFN-3, [4.0  • 
1.6] eosinophils/mm at 24 h, mean  _  SD; n  --  5, p <0.001) 
(Fig.  2).  The preinjection with rIFN-'y (60,000 U/d)  also 
decreased the OVA-induced eosinophil infiltration at 9-48 h 
by 96-97%  (0.6  •  0.4  eosinophils/mm  at  24  h;  n  --  6, 
p  <0.001) (Fig. 2). In addition,  a single intraperitoneal ad- 
ministration of rIFN-v (30,000 U) 2 h before OVA inhala- 
tion also significantly decreased the OVA-induced eosinophil 
infiltration at 24 h by 68% (control [17.0  __ 3.4] vs. rIFN-y 
[5.5  _+  2.9]  eosinophils/mm;  n  =  10, p  <0.001). 
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Figure 3.  Effect of murine rIFN-3, on antigen-induced  T cell infiltra- 
tion in mouse trachea.  CD4 + and CD8 + T  cell infiltration in the tra- 
chea was examined at 24 h (n =  10 mice in each group). (*) Significantly 
different from the mean value of the control response (saline); *y <0.001. 
The dose-dependent effect of rlFN-3, on antigen-induced 
eosinophil infiltration of the trachea was then examined. The 
intraperitoneal preinjections with rlFN-qr (600-60,000 U/d) 
from 1 d before OVA inhalation decreased the OVA-induced 
eosinophil infiltration at 24 h in a dose-dependent manner 
with  a  significant  minimum effect  at  600  U/d  (n  =  5, 
p <0.01) and an almost complete inhibition at >20,000 U/d 
(n =  5, p <0.001) (Fig. 2). However, the preinjections with 
rlFN-3' (600-60,000 U/d) did not significantly affect blood 
eosinophil counts at 24 h compared with those of control 
mice (data  not shown). 
Effect of lFN-  7 on Antigen-induced T Cell Infiltration into the 
Trachea.  IFN-?  decreased  antigen-induced CD4 + T  cell 
infiltration into the mouse trachea. The intraperitoneal prein- 
jection with rlFN-? (6,000 and 60,000 U/d) from 1 d before 
OVA inhalation significantly decreased OVA-induced CD4 + 
T  cell infiltration in the trachea of OVA-sensitized mice at 
24 h by 54 and 70%, respectively (n  =  10, p <0.001) (Fig. 
3).  In  contrast,  the  preinjection  with  rlFN-3,  did  not 
significantly affect CD8 + T call infiltration into the trachea 
(n =  10) (Fig. 3). In addition, there were no significant changes 
in CD4 + and CD8 + T ceU subsets of spleen cells by FACS  | 
(Becton Dickinson & Co., Mountain View, CA) analysis after 
the intraperitoneal administration of rIFN-3, (60,000  U/d) 
(data  not shown). 
Effect of  Anti-IFN-y mAt~  Pretreatment with anti-IPN-3, 
mAb (increased antigen-induced eosinophil recruitment into 
the mouse trachea.  The intraperitoneal preinjection with 
anti-murine IFN-? mAb (K4-6A2;  1 mg) 24 h before the 
inhaled OVA challenge significantly increased OVA-induced 
eosinophil infiltration into the mouse trachea at 9 h by 60% 
(control rat IgG [8.1  •  2.1] vs. anti-IFN-y mAb [12.9  +_ 
3.3] eosinophils/mm; n  =  10, p <0.05) (Fig. 4). The prein- 
jection with anti-IFN-? mAb also increased the OVA-induced 
eosinophil infiltration at 24 h by 54% (control rat IgG [18.9 
•  4.7] vs. anti-IFN-y mAb [29.0  •  6.9] eosinophils/mm; 
n  =  10, p  <0.05)  (Fig.  4). 
The preinjection with anti-IFN-3,  mAb increased OVA- 
induced CD4 + T  cell infiltration in the trachea  at 9 and 
24 h by 53 and 38%, respectively  (n  =  6, p <0.05)  (Fig. 
4). In contrast, the preinjection with anti-IFN-~ mAb de- 
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Figure  4.  Effect of anti-murine IFN-~/mAb on antigen-induced  eo- 
sinophil and T cell infiltration in mouse trachea. OVA-sensitized mice were 
injected intraperitoneally  with anti-routine IFN-~t mAb R4-6A2 (I) or 
rat IgG ([7) 24 h before OVA inhalation,  and the eosinophil  and T cell 
infiltration  in the trachea was examined at 9 and 24 h (n  =  6-10 mice 
in each group). (* and  **) Significantly different from the mean value 
of the corresponding  control response (rat IgG): *p <0.05; * *p <0.005. 
creased the OVA-induced CD8 § T  cell infiltration at 24 h 
by 54%  (n  =  6, p <0.005)  (Fig.  4). 
Discussion 
We have previously shown that antigen-induced eosino- 
phil recruitment into the airways of sensitized mice is medi- 
ated by CD4 + T  cells and their cytokine IL-5 (1). In this 
study, we show that IFN-? regulates antigen-induced eosin- 
ophil recruitment into the tissue by inhibiting CD4 + T cell 
infiltration.  We found that the administration of routine 
rlFN~ effxdently prevented the eosinophil infiltration induced 
by antigen inhalation in the trachea of sensitized mice (Fig. 
2), and that the inhibition of the eosinophil infiltration was 
associated  with  the decrement of CD4 §  T  cell but  not 
CD8 + T  cell infiltration (Fig. 3).  However,  there were no 
significant changes in the number of blood eosinophils nor 
of splenic CD4 + and CD8 § T  cells in the treatment with 
rIFN-% On the other hand, we also found that the adminis- 
tration of anti-murine IFN-'r  mAb enhanced the antigen- 
induced eosinophil and CD4 + T cell infiltration in the tra- 
chea (Fig. 4). Taken together with the results of a previous 
study (1), these results suggest that IFN-? prevents antigen- 
induced CD4 + T cell infiltration into the tissue and thereby 
decreases the following CD4 + T cell and IL-5-dependent eo- 
sinophil recruitment into the tissue. 
575  Iwamoto et al.  Brief Definitive Report IFN-3' has been shown to inhibit  Th2 cell proliferation 
in vitro (3,  4) and antagonize  Th2-type responses in vivo 
(5, 8, 9). It has also been suggested that the inhibitory effect 
of IFN-3, on the in vivo Th2-type responses occurs at the 
time of initial  CD4 §  T  cell activation during  the antigen 
presentation (9, 10). Therefore, it is possible that the inhibi- 
tory effect of IFN-3t (both exogenous rlFN-3' and endoge- 
nous IFN-3') on antigen-induced  CD4 + T  cell infiltration 
into the trachea of sensitized mice might be due to the inter- 
ference of initial Th2 cell activation by the presence of IFN-3' 
at  the time of antigen  inhalation. 
IFN-~/has also been shown to activate vascular endothelial 
cells  to increase  the expression of adhesion  molecules (11) 
through which the adhesion of eosinophils to endothelial cells 
is increased (12). Therefore, it seems unlikely that the direct 
effect of IFN-3' on vascular endothelial cells is involved in 
the inhibition of antigen-induced eosinophil infiltration into 
the tissue.  It is also unlikely that IFN-3, directly acts on eo- 
sinophils  and  thereby  inhibits  the  antigen-induced  IL-5- 
dependent eosinophil infiltration, because it has been demon- 
strated that IFN-'y is an activator for eosinophils to prolong 
the  survival and enhance  the cytotoxicity (13). 
Our  finding  that  rlFN-3~  effectively prevents  antigen- 
induced eosinophil recruitment into the tissue suggests that 
rIFN-3, would be useful for the treatment of atopic diseases 
such as asthma and atopic dermatitis.  Because asthma is charac- 
terized by allergic eosinophil infiltration in the airways, treat- 
ment with rIFN-y would reduce airway eosinophil infiltra- 
tion in asthma.  Indeed, it has been reported that treatment 
with rIFN-'y decreases cutaneous lesions of atopic dermatitis 
(14).  In  summary,  we  have  shown  that  IFN-3'  regulates 
antigen-induced eosinophil recruitment into the tissue, indi- 
cating that IFN-3' is a potent modulator of allergic late-phase 
reaction. 
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